TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Gross profit 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual gross profit history from SEC filings — each fiscal year as reported.
$8.9BFY2025 · since FY2016: $11.7B → $8.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.9B | +10.8% |
| FY2024 | $8.1B | +5.5% |
| FY2023 | $7.6B | +9.6% |
| FY2022 | $7.0B | -8.2% |
| FY2021 | $7.6B | -1.7% |
| FY2020 | $7.7B | +2.5% |
| FY2019 | $7.5B | -9.1% |
| FY2018 | $8.3B | -21.8% |
| FY2017 | $10.6B | -8.9% |
| FY2016 | $11.7B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TEVA financial trends
TEVA RevenueTEVA Net incomeTEVA Net marginTEVA Gross marginTEVA Operating incomeTEVA Operating marginTEVA Operating cash flowTEVA Free cash flowTEVA Capital expendituresTEVA Return on equityTEVA Stock buybacksTEVA Dividends paidTEVA Total assetsTEVA Total liabilitiesTEVA Shareholders’ equityTEVA overview →